- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
内镜黏膜下挖除术治疗食管固有肌层肿瘤.pdf
内镜黏膜下挖除术治疗食管固有肌层肿瘤
钟芸诗 时强 姚礼庆 周平红 徐美东 陈巍峰 李全林 蔡贤黎 王萍
[摘要] 目的 探讨内镜黏膜下挖除术(ESE)治疗食管固有肌层肿瘤的临床价值。方法 回
顾性分析2008年12月至2010年12月27例行ESE治疗的食管固有肌层肿瘤患者的资料,评价治
疗的可行性、安全性和疗效。结果 27例患者共29个病灶,病变直径0.5 ~3.0 cm,平均(1.25±
0.70 )cm。切除率96. 3% (26/27),1例患者中转手术治疗。中位手术时间74(30 ~120)min。术
后病理诊断平滑肌瘤26例,间质瘤1例。2例术中穿孔伴气胸,金属夹夹闭创面后予胸腔闭式引
流,未行开胸手术修补。中位随访时间12(3 ~27)个月,未见复发病例。结论 对于直径小于
3.0 cm、腔内生长为主的食管固有肌层肿瘤,ESE治疗具有安全、有效的特点,并可提供完整的病理
学诊断资料,进一步扩大了内镜治疗的范围。
食管;固有肌层; 内镜黏膜下挖除术
Endoscopic submucosal excavation of esophageal submucosal tumors originating from the muscularis
propria layer ZHONG Yun-shi SHI Qiang YAO Li-qing ZHOU Ping-hongXU Mei-dong CHEN Wei-
fengLI Quan-linCAI Xian-li, WANG Ping Endoscopy Center, Zhongshan Hospital, Fudan University,
Shanghai 200032, China
[ Abstract] Objective To study the value of endoscopic submucosal excavation (ESE) for esopha
geal submucosal tumors originating from the muscularis propria layer. Methods Data of 27 patients with 29
lesions in esophageal muscularis propria treated with ESE from Dec. 2008 to Dec. 2010 were retrospected.
Feasibility, effects and safety were evaluated accordingly. Results Of 27 patients,there were 17 males and
10 females. Mean age was 50(22 ~62)yrs,and mean diameter of the lesions was 1.25 ±0. 70 (0. 5 ~3.0)
cm. Resection rate was 96. 3% (26/27). One failed case with tumor residual after ESE received additional
operation. The median procedure time was 74 (30-120) min. Pathological examination confirmed leiomyoma
in 26 cases and gastrointestinal stromal tumor (GISTs) in 1 case. Perforation during operation occurred in 2
cases, accompanied with pneumothorax. They were treated with closed thoracic drainage, without surgery.
The median follow-up time was 12 months (3 to 27 months), and no recurrence was found. Conclusion
ESE is a safe and effective therapy for the esophageal tumor smaller than 3.0 cm from the muscularis prop
Esophagus; Muscularis propria; Endoscopic submucosal
文档评论(0)